Treatment of relapsed acute myeloid leukaemia.

@article{Kell2006TreatmentOR,
  title={Treatment of relapsed acute myeloid leukaemia.},
  author={Jonathan Kell},
  journal={Reviews on recent clinical trials},
  year={2006},
  volume={1 2},
  pages={103-11}
}
Acute myeloid leukaemia (AML) is the most common form of acute leukaemia among adults with an incidence that increases with age. Modern induction chemotherapy will result in complete remission in 50-90% of patients with de novo disease, but between 10 and 25% of patients will have primary refractory disease and the majority of those who gain remission will… CONTINUE READING